Page last updated: 2024-10-30

lorazepam and Craniopharyngioma

lorazepam has been researched along with Craniopharyngioma in 1 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Craniopharyngioma: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Massengale, J1
Tafti, BA1
Large, L1
Skirboll, S1

Other Studies

1 other study available for lorazepam and Craniopharyngioma

ArticleYear
Reversal of preoperative catatonic state by surgical resection of an adult-onset craniopharyngioma: case report and review of the literature.
    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2009, Volume: 22, Issue:1

    Topics: Brain; Catatonia; Craniopharyngioma; Hormones; Humans; Hypnotics and Sedatives; Lorazepam; Male; Mid

2009